Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study
NCT02378246 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1337
Last updated 2025-08-26
Summary
THE ULTIMATE GOAL of this project is to answer the question "In MILD IODINE DEFICIENCY (ID), should a tablet with vitamins and minerals, including 150 μg iodine/day be administered to pregnant women with a normal diet, to attain a normal cognitive development of the fetus or is there no cognitive deficit from mild ID and no extra iodine is needed?". To answer this question, the investigators planned a randomized, placebo-controlled trial of micronutrient supplementation during pregnancy in Sweden (SWIDDICH) with the follow-up of childrens' COGNITIVE DEVELOPMENT at 18 months, 3.5, 7 and 14 years.
Iodine deficiency (ID) is associated with thyroid morbidity and, especially in children, with impaired cognitive development. Sweden introduced iodine fortification of table salt 1936 and mental retardation due to severe ID is eradicated. Is mild ID during pregnancy also eradicated? If not, is this of importance? A national study performed by the investigators in 2007 showed iodine sufficiency in general population, but there are no pregnancy data. Local studies have raised concerns for mild ID during pregnancy in Sweden and a trans-sectional national study is currently ongoing.
The burning question for Sweden and the whole world is: is mild ID during pregnancy of importance for the developing brain of the fetus? Two large observational studies have shown association between mild ID during pregnancy and lower verbal IQ or educational performance at school-aged children. The world needs a randomized placebo-controlled trial (RTC) comparing the cognitive outcome in children exposed to mild ID during fetal life with children exposed to normal iodine levels during fetal life.
Our HYPOTHESIS is that pregnant women in Sweden have mild ID and that children exposed to mild ID during fetal life have a lower cognitive development, compared to children to mothers taking daily tablet with vitamins and minerals, including 150 ug iodine during pregnancy.
The MAIN AIM of the SWIDDICH trial is to determine if children exposed to deficient micronutrition including mild iodine deficiency (ID) during fetal life achieve worse cognitive development compared to children exposed to normal iodine status reached by maternal iodine supplementation.
Conditions
- Thyroid Gland; Node
- Pregnancy
- Cognitive Developmental Delay
Interventions
- DIETARY_SUPPLEMENT
-
Iodine
- DIETARY_SUPPLEMENT
-
Placebo
Sponsors & Collaborators
-
Sahlgrenska University Hospital
collaborator OTHER -
Göteborg University
lead OTHER
Principal Investigators
-
Helena Filipsson Nyström, Ass Prof · Center for Endocrinology and Metabolism, SAhlgrenska University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2029-06-30
- Completion
- 2032-06-30
Countries
- Sweden
Study Locations
More Related Trials
-
Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy
NCT00388297 ·Status: COMPLETED ·Phase: PHASE3
-
Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?
NCT00505479 ·Status: UNKNOWN
-
Thyroid Function Throughout Pregnancy With and Without Iodine Supplementation
NCT00831402 ·Status: COMPLETED ·Phase: NA
-
The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease
NCT03761602 ·Status: UNKNOWN
-
Mothers and Babies at Yorkhill Thyroid Health Cohort
NCT02390128 ·Status: UNKNOWN
-
The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children
NCT00147433 ·Status: UNKNOWN
-
Serum Thyroglobulin as a Marker of Iodine Status During Pregnancy
NCT02927119 ·Status: COMPLETED
-
A Trial for the Evaluation of the Treatment and Outcome of Hyperthyroidism With Iodized Salt and Non Iodized Salt
NCT03444246 ·Status: UNKNOWN ·Phase: NA
-
Iodine Status in Pregnant Women in Israel
NCT03120221 ·Status: UNKNOWN
-
Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation
NCT03078140 ·Status: COMPLETED ·Phase: NA
-
Swiss National Iodine Survey 2020
NCT04524013 ·Status: COMPLETED
-
Thyroid Functions in Children With Congenital Heart Diseases
NCT05103774 ·Status: UNKNOWN
-
Iodine Status Monitoring in PortUguese Pregnant woMen: Impact of Supplementation
NCT04010708 ·Status: COMPLETED
-
Longitudinal Study on the Influence of Iodine Nutrition Status on Thyroid Function of Childbearing Age Women During Pregnancy and 6 Weeks Postpartum
NCT05677581 ·Status: RECRUITING
-
the Effect of Universal Salt Iodization on Thyroid Diseases
NCT01838629 ·Status: COMPLETED
-
Selenium Supplementation in Pregnancy
NCT01465867 ·Status: COMPLETED ·Phase: NA
-
Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction
NCT02491008 ·Status: COMPLETED ·Phase: PHASE4
-
Community Salt Testing and Relation of Iodine Intake to Visual Information Processing of Ethiopian Infants
NCT03889431 ·Status: COMPLETED ·Phase: NA
-
Iodine Supplementation in Obesity
NCT01985204 ·Status: COMPLETED ·Phase: NA
-
The Relationship Between Urine Iodine, Urine Bisphenol A and Autoimmune Thyroid Disease in Reproductive Women
NCT03932487 ·Status: UNKNOWN
-
L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia
NCT01306227 ·Status: COMPLETED ·Phase: PHASE3
-
Thyroid Dysfunction and Obstetric Complications
NCT02815501 ·Status: WITHDRAWN
-
Preoperative Administration of Lugols Solution in Toxic Thyroid Diseases (TD): A Prospective Study
NCT06176976 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Maternal Autoimmune Thyroid Disease and Fetal Thyroxin
NCT01528904 ·Status: COMPLETED
-
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
NCT00360074 ·Status: COMPLETED ·Phase: PHASE4